DNM2 and cardiovascular disorder: The identification of mitochondrial, ER, calcium-signaling, synaptic, apoptotic, proteostatic, and cytoskeletal proteins accumulating in Alzheimer’s disease and cardiovascular disease aggregates suggests their potential as biomarkers for diagnosis and progression tracking of such diseases.